ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/4/2023ACC: 0001209191-23-001081
Officer· Interim CFO
Since Jun 2021
-354.00
Net shares
Net seller
$53.10
Total sold
0
Open market trades
0B · 0S
1
Total transactions
354.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−354.00
Price / share
$0.15
Trade value
$53.10
% of position
0.2%
12/31/2022
173.36K→173K
Total
Net shares
−354.00
Net value
-$53.10
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2022 | F · Tax Withholding | −354.00 | $0.15 | $53.10 | 0.2% | 173.36K | 173K |
| Total | −354.00 | -$53.10 | ||||||
Derivative Transactions0
No derivative transactions reported